Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation.
PML: The Dark Side of Immunotherapy in Multiple Sclerosis.
Quality improvement and practice-based research in neurology using the electronic medical record.
Fulminant Demyelinating Diseases of the Central Nervous System.
Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.
Induction of intestinal Th17 cells by segmented filamentous bacteria.
Sources of information and behavioral patterns in online health forums: qualitative study.
Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors.
Regulatory T cell proliferative potential is impaired in human autoimmune disease.
Interaction between passive smoking and two HLA genes with regard to multiple sclerosis risk.
From the periphery to the brain: Lipocalin-2, a friend or foe?
Multiple sclerosis: Managing patients in primary care.
CRYAB modulates the activation of CD4+ T cells from relapsing-remitting multiple sclerosis patients.
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.
Obstructive sleep apnea is associated with fatigue in multiple sclerosis.
[Cognitive impairment in multiple sclerosis].
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.
MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.
Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica.
Disease activity and disability evolution under glatiramer acetate: A clinical approach.
ADC evaluation of the corticospinal tract in multiple sclerosis.
A prospective cohort study of vitamin D in optic neuritis recovery.
Induction of Experimental Autoimmune Encephalomyelitis With Recombinant Human Myelin Oligodendrocyte Glycoprotein in Incomplete Freund's Adjuvant in Three Non-human Primate Species.
The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis.
Pages
« first
‹ previous
…
395
396
397
398
399
400
401
402
403
…
next ›
last »